Micro-Cap Stocks Surge Amid Biotech Breakthroughs
By ATTN Desk · Editorial oversight: Sean Han
Market Recap: June 27, 2025
Introduction
U.S. equity markets saw pronounced volatility on June 27, led by a slate of small-cap and micro-cap stocks posting triple-digit gains. Biotechnology, industrials and e-commerce logistics names dominated the leaderboard as investors reacted to fresh clinical data, grant awards and strategic expansions. Overall trading volume was skewed toward names with low float and high news flow, resulting in outsized price moves across the market.
Key Movers Table
| Ticker | ATTN Price | Current Price | Volume | Price Change % |
|---|---|---|---|---|
| LCFY | 4.30 | 8.72 | 58,757,720 | 102.61% |
| CYN | 9.91 | 16.20 | 34,854,090 | 63.44% |
| BBLG | 2.89 | 4.29 | 12,583,264 | 48.80% |
| INMB | 2.33 | 5.40 | 39,332,047 | 132.34% |
| NAOV | 0.92 | 1.13 | 20,448,452 | 23.36% |
| GVH | 0.04 | 0.13 | 249,906,544 | 199.13% |
| HSDT | 0.18 | 0.22 | 7,604,128 | 22.86% |
| GCTK | 5.43 | 6.42 | 2,504,292 | 18.27% |
| RMSG | 1.59 | 1.84 | 448,475 | 16.09% |
| WFF | 0.46 | 3.70 | 17,479,761 | 797.55% |
| TLYS | 1.04 | 1.32 | 1,626,658 | 27.42% |
| MRC | 13.80 | 14.90 | 3,683,954 | 7.89% |
| OTRK | 0.44 | 0.52 | 1,970,586 | 18.00% |
| OST | 0.20 | 0.33 | 83,420,874 | 64.23% |
| LYRA | 8.29 | 9.39 | 549,287 | 13.31% |
| RCT | 0.95 | 3.04 | 53,155,469 | 221.60% |
| LIMN | 5.18 | 10.10 | 448,361 | 95.00% |
| DAIC | 5.13 | 9.00 | 260,348 | 75.47% |
| VOR | 0.77 | 1.04 | 34,766,815 | 35.91% |
| CTOR | 2.59 | 4.56 | 8,104,898 | 75.85% |
Micro-cap stocks by Allison Saeng
Overall Market Trends
Equities exhibited a clear risk-on posture, with micro-cap names significantly outperforming broader indices. Biotech and healthcare development companies led sector performance after clinical trial updates and regulatory milestones. Names with recent IPOs or new product launches attracted outsized trading interest, contributing to divergent performance between small-cap leaders and the broader market.
Highlights of Significant Moves
- WFF (WF Holding Ltd) vaulted 797.55% to $3.70 on volume of 17.5 million shares following its recent IPO. The company’s announcement of expansion into digital–asset advisory services spurred the rally.
- RCT (RedCloud Holdings PLC) climbed 221.60% to $3.04, trading 53 million shares after pricing its IPO and securing favorable analyst coverage on projected revenue growth.
- GVH (Globavend Holdings Ltd) surged 199.13% to $0.13 on exceptionally high volume (250 million shares) after confirming a HK$7 million government grant and outlining plans for a China market entry.
- INMB (INmune Bio, Inc.) advanced 132.34% to $5.40 as investors cheered Phase II trial progress in Alzheimer’s disease and prostate cancer studies, driving volume of 39 million shares.
Other notable double-digit gainers included DAIC (+75.47%), CTOR (+75.85%) and OST (+64.23%), each benefitting from product updates, grant funding or strategic partnerships.
tl;dr
- Micro-caps led the market; biotech and recent IPOs showed the largest surges.
- WFF jumped nearly 800% post-IPO; RCT rose 221% on new listing enthusiasm.
- GVH climbed 199% amid grant funding and expansion plans in China.
- INmune Bio soared 132% on positive clinical trial news.
- High-volume, low-float stocks drove today’s volatility and sector rotation.